Flavonoids, a subclass of polyphenols, have demonstrated potential in ameliorating insulin resistance, a central feature of metabolic syndrome, by modulating signaling pathways such as the phosphoinositide 3-kinase/protein kinase B (PI3K/Akt) pathway. Here, AKT1 is linked to metabolic syndrome.